Evidence map›Paper›PMID 41528780›Full record

ArticleJournal of medical microbiology2026

Effect of evolocumab on the gut microbiota in patients with acute myocardial infarction.

Jie Zou, Yunzhu Peng, Hongyan Cai, Qinghua Zhong, Na Zhu, Wenyi Gu, Fazhi Yang, Tao Shi, Sirui Yang, Lixing Chen

Abstract read
In one paragraph

Article in Journal of medical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jie ZouDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, PR China.
Yunzhu PengDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, PR China.
Hongyan CaiDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, PR China.
Qinghua ZhongDepartment of Paediatrics, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, PR China.
Na ZhuDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, PR China.
Wenyi GuDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, PR China.
Fazhi YangDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, PR China.
Tao ShiDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, PR China.
Sirui YangDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, PR China.
Lixing ChenDepartment of Cardiology, Kunming Medical University First Affiliated Hospital, Kunming, Yunnan, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, Monoclonal, HumanizedAnticholesteremic AgentsGastrointestinal MicrobiomeMyocardial InfarctionAgedBacteriaFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedProspective StudiesRNA, Ribosomal, 16SAntibodies, Monoclonal, HumanizedAnticholesteremic AgentsevolocumabHydroxymethylglutaryl-CoA Reductase InhibitorsRNA, Ribosomal, 16S16S rRNA sequencingacute myocardial infarctionevolocumabgut microbiotaoutcome

Identifiers

PMID41528780
PMCPMC12799316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.